We are live on
!
Find out more
Viking Therapeutics
VKTX
VKTX
12 hedge funds and large institutions have $1.13M invested in Viking Therapeutics in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
49% more capital invested
Capital invested by funds: $758K → $1.13M (+$368K)
0.08% more ownership
Funds ownership: 3.16% → 3.23% (+0.08%)
0% more funds holding
Funds holding: 12 → 12 (0)
Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$143K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$84.5K |
| 3 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$12.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.3K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$2.62K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$35K |
| 2 |
Morgan Stanley
New York
|
-$21.3K |